Novartis Investigative Site

Warsaw, Masovian Voivodeship 04-305

2 studies enrolling now · 5 studies all time

What they study most

Atopic Dermatitis, Cardiovascular Disease and Lipoprotein(a), Cushing's Disease, Generalized Myasthenia Gravis, Hidradenitis Suppurativa

Studies at this site

• A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG. — Recruiting now
• Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis — Recruiting now
• A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa — Running, not enrolling
• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease — Completed